USPTO serial 79246244
KUROS
Reviewed by CopyMark Law Group
Reg. 6155634Status 708Renewal
- Filing date
- Status date
- Registration date
- Sep 22, 2020
- Examiner
- MCBRIDE, CAMERON L
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with KUROS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
Leigh Ann Lindquist SUGHRUE MION, PLLC2000 Pennsylvania Avenue NW, Suite 9000Washington, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical substances and preparations in the nature of protein [ and peptide preparations ] , in particular for the formation or regeneration of missing or damaged body parts, specifically, parts of the musculoskeletal system, in particular bones; goods of synthetic and natural origin for medical use, in particular consisting of [ fibrin and ] polyethylene glycol, for the retention or the delayed release of [ peptides or ] proteins, specifically growth factors and hormones which are the substances which stimulate the growth of an organism or maintain it, namely, growth factors [ and hormones ] ; biomedical and biotechnology products for medical use, namely, orthobiologics that are substances which stimulate the growth or maintenance of musculoskeletal tissues in the nature of growth factors [ and hormones ] ; orthobiologics for medical use for the permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous musculoskeletal tissues, in particular for bones, [ intervertebral discs, cartilage, fat and muscle tissues, ] namely, orthobiologics in the nature of synthetic matrices [ , growth factors and hormones] ; [ permanent and temporary medical adhesives for binding internal tissue compatible with the body, in particular for human or animal organs, soft tissues, and hard tissues for medical use; separation products for medical use compatible with the body, intended to prevent organs and soft parts from sticking together, namely, anti-adhesion products in the nature of anti-adhesion gels for use during and following surgery; ] modified implants comprising living tissue in endogenous material, tissues, cells and molecules for replacing and assisting the function of missing or damaged body parts; [ biological endogenous soft tissue, grafts in particular for fat tissue and tissue replacement; biological endogenous hard and soft tissue, grafts in particular for bones for transplantation purposes; ] natural biomaterials for bone [ , cartilage, vessel, tissue and fat tissue ] replacement, namely, biological tissue grafts | ACTIVE | — |
| 010 | Synthetic biomaterials for the substitution of tissue, for the recovery, maintenance and the repair of the function of diseased or damaged human or animal tissue for medical purposes; surgical synthetic implants and modified surgical implants for replacing and assisting with the function of missing or damaged body parts, all comprising artificial material; synthetic hard and soft prosthetic tissues, in particular synthetic bone substitution for surgical use in the nature of being for transplantation [ and diagnostic ] purposes and for bone, vessel, tissue [ and fat tissue substitution ] ; modified surgical implants for replacing and assisting with the function of missing or damaged body parts, all comprising artificial material | ACTIVE | — |
| 041 | Medical product training for doctors and medical personnel | ACTIVE | — |
| 042 | [ Research and development in the field of biomedicine and biomaterials; engineering services provided by a pharmaceutical or biotechnological company, in particular by a pharmacologist, a biochemist, a scientist specialized in biomaterials or a biotechnologist in the field of tissue engineering; scientific research services for medical use ] | SECTION 71 - CANCELLED | — |
| 044 | Medical services provided by a doctor; providing medical advice in the field of orthobiologics, adhesive barriers and tissue sealants | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kuros Biosurgery AG
- Other trademarks owned by Kuros Biosurgery AG
- Other trademarks owned by Kuros Biosurgery AG
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named KUROS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Oct 29, 2026 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Oct 19, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 22, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Sep 22, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 13, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 30, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 11, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 11, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 22, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 22, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 10, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 7, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 7, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 17, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 17, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 17, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 4, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 14, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 8, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 22, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 22, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 18, 2019 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Nov 18, 2019 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Nov 18, 2019 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Oct 30, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 17, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 12, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 2, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 2, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 2, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 11, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 11, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 11, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 5, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 15, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 15, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 7, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 6, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 30, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 28, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 26, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 22, 2018 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |